Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Double-Blinded, Sham-Control Study to Evaluate the Efficacy and Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults

NCT03727100 is registered in ClinicalTrials.gov with Sollis Therapeutics, Inc. as lead sponsor.

NCT NCT03727100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03727100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Double-Blinded, Sham-Control Study to Evaluate the Efficacy and Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
Lead sponsor
Sollis Therapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
October 16, 2018
Completion date
July 18, 2020
Enrollment
207 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

lumbosacral radiculopathy